1.
Al-Humaidhi A. A review study of targeting of AAK1 and JAK1/2 using baricitinib in COVID-19 infected human cells. KCMJ [Internet]. 24Jul.2020 [cited 16May2021];16(supplement):9-5. Available from: https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/176